Mixed neuroendocrine–nonneuroendocrine neoplasms of the gastrointestinal system: An update
Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the digestive tract are a rare heterogeneous group of tumors that present many challenges in terms of diagnosis and treatment. Over the years, the diagnostic criteria, classification, and clinical behavior of these tumors have been the sub...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 28; no. 8; pp. 794 - 810 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Inc
28.02.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the digestive tract are a rare heterogeneous group of tumors that present many challenges in terms of diagnosis and treatment. Over the years, the diagnostic criteria, classification, and clinical behavior of these tumors have been the subjects of ongoing debate, and the various changes in their nomenclature have strengthened the challenges associated with MiNENs. This review is performed to provide an understanding of the key factors involved in the evolution of the designation of these tumors as MiNEN, highlight the current diagnostic criteria, summarize the latest data on pathogenesis and provide information on available treatments. Moreover, this work seeks to increase the awareness about these rare neoplasms by presenting the clinicopathological features and prognostic factors that play important roles in their behavior and discussing their different regions of origin in the gastrointestinal system (GIS). Currently, the MiNEN category also includes tumors in the GIS with a nonneuroendocrine component and epithelial tumors other than adenocarcinoma, depending on the organ of origin. Diagnosis is based on the presence of both morphological components in more than 30% of the tumor. However, this value needs to be reconfirmed with further studies and may be a limiting factor in the diagnosis of MiNEN by biopsy. Furthermore, available clinicopathological data suggest that the inclusion of amphicrine tumors in the definition of MiNEN is not supportive and warrants further investigation. The diagnosis of these tumors is not solely based on immunohistochemical findings. They are not hybrid tumors and both components can act independently; thus, careful grading of each component separately is required. In addition to parameters such as the metastatic state of the tumor at the time of diagnosis and the feasibility of surgical resection, the aggressive potential of both components has paramount importance in the choice of treatment. Regardless of the organ of origin within the GIS, almost MiNENs are tumors with poor prognosis and are frequently encountered in the elderly and men. They are most frequently reported in the colorectum, where data from molecular studies indicate a monoclonal origin; however, further studies are required to provide additional support for this origin. |
---|---|
AbstractList | Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the digestive tract are a rare heterogeneous group of tumors that present many challenges in terms of diagnosis and treatment. Over the years, the diagnostic criteria, classification, and clinical behavior of these tumors have been the subjects of ongoing debate, and the various changes in their nomenclature have strengthened the challenges associated with MiNENs. This review is performed to provide an understanding of the key factors involved in the evolution of the designation of these tumors as MiNEN, highlight the current diagnostic criteria, summarize the latest data on pathogenesis and provide information on available treatments. Moreover, this work seeks to increase the awareness about these rare neoplasms by presenting the clinicopathological features and prognostic factors that play important roles in their behavior and discussing their different regions of origin in the gastrointestinal system (GIS). Currently, the MiNEN category also includes tumors in the GIS with a nonneuroendocrine component and epithelial tumors other than adenocarcinoma, depending on the organ of origin. Diagnosis is based on the presence of both morphological components in more than 30% of the tumor. However, this value needs to be reconfirmed with further studies and may be a limiting factor in the diagnosis of MiNEN by biopsy. Furthermore, available clinicopathological data suggest that the inclusion of amphicrine tumors in the definition of MiNEN is not supportive and warrants further investigation. The diagnosis of these tumors is not solely based on immunohistochemical findings. They are not hybrid tumors and both components can act independently; thus, careful grading of each component separately is required. In addition to parameters such as the metastatic state of the tumor at the time of diagnosis and the feasibility of surgical resection, the aggressive potential of both components has paramount importance in the choice of treatment. Regardless of the organ of origin within the GIS, almost MiNENs are tumors with poor prognosis and are frequently encountered in the elderly and men. They are most frequently reported in the colorectum, where data from molecular studies indicate a monoclonal origin; however, further studies are required to provide additional support for this origin. Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the digestive tract are a rare heterogeneous group of tumors that present many challenges in terms of diagnosis and treatment. Over the years, the diagnostic criteria, classification, and clinical behavior of these tumors have been the subjects of ongoing debate, and the various changes in their nomenclature have strengthened the challenges associated with MiNENs. This review is performed to provide an understanding of the key factors involved in the evolution of the designation of these tumors as MiNEN, highlight the current diagnostic criteria, summarize the latest data on pathogenesis and provide information on available treatments. Moreover, this work seeks to increase the awareness about these rare neoplasms by presenting the clinicopathological features and prognostic factors that play important roles in their behavior and discussing their different regions of origin in the gastrointestinal system (GIS). Currently, the MiNEN category also includes tumors in the GIS with a nonneuroendocrine component and epithelial tumors other than adenocarcinoma, depending on the organ of origin. Diagnosis is based on the presence of both morphological components in more than 30% of the tumor. However, this value needs to be reconfirmed with further studies and may be a limiting factor in the diagnosis of MiNEN by biopsy. Furthermore, available clinicopathological data suggest that the inclusion of amphicrine tumors in the definition of MiNEN is not supportive and warrants further investigation. The diagnosis of these tumors is not solely based on immunohistochemical findings. They are not hybrid tumors and both components can act independently; thus, careful grading of each component separately is required. In addition to parameters such as the metastatic state of the tumor at the time of diagnosis and the feasibility of surgical resection, the aggressive potential of both components has paramount importance in the choice of treatment. Regardless of the organ of origin within the GIS, almost MiNENs are tumors with poor prognosis and are frequently encountered in the elderly and men. They are most frequently reported in the colorectum, where data from molecular studies indicate a monoclonal origin; however, further studies are required to provide additional support for this origin.Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the digestive tract are a rare heterogeneous group of tumors that present many challenges in terms of diagnosis and treatment. Over the years, the diagnostic criteria, classification, and clinical behavior of these tumors have been the subjects of ongoing debate, and the various changes in their nomenclature have strengthened the challenges associated with MiNENs. This review is performed to provide an understanding of the key factors involved in the evolution of the designation of these tumors as MiNEN, highlight the current diagnostic criteria, summarize the latest data on pathogenesis and provide information on available treatments. Moreover, this work seeks to increase the awareness about these rare neoplasms by presenting the clinicopathological features and prognostic factors that play important roles in their behavior and discussing their different regions of origin in the gastrointestinal system (GIS). Currently, the MiNEN category also includes tumors in the GIS with a nonneuroendocrine component and epithelial tumors other than adenocarcinoma, depending on the organ of origin. Diagnosis is based on the presence of both morphological components in more than 30% of the tumor. However, this value needs to be reconfirmed with further studies and may be a limiting factor in the diagnosis of MiNEN by biopsy. Furthermore, available clinicopathological data suggest that the inclusion of amphicrine tumors in the definition of MiNEN is not supportive and warrants further investigation. The diagnosis of these tumors is not solely based on immunohistochemical findings. They are not hybrid tumors and both components can act independently; thus, careful grading of each component separately is required. In addition to parameters such as the metastatic state of the tumor at the time of diagnosis and the feasibility of surgical resection, the aggressive potential of both components has paramount importance in the choice of treatment. Regardless of the organ of origin within the GIS, almost MiNENs are tumors with poor prognosis and are frequently encountered in the elderly and men. They are most frequently reported in the colorectum, where data from molecular studies indicate a monoclonal origin; however, further studies are required to provide additional support for this origin. |
Author | Elpek, Gulsum Ozlem |
Author_xml | – sequence: 1 givenname: Gulsum Ozlem surname: Elpek fullname: Elpek, Gulsum Ozlem |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35317101$$D View this record in MEDLINE/PubMed |
BookMark | eNp1UctO3TAQtSpQudBuu0RZsknwK4ndBRJCfSCB2LCsZDnO5GKU2BfbgbLjH_jDfklN7wVBJVYjzZzHzJxdtOW8A4S-EFyxlovDu-tldUtFZUXVSv4BLSglsqSC4y20IBi3pWS03UG7MV5jTBmr6Ue0w2pGWoLJAv06t7-hLxzMwYPrvQnWwZ-Hx2zztpchfjXqOMXCD0W6gmKpYwreugQxWafHIt7HBNPX4tgV86rXCT6h7UGPET5v6h66_P7t8uRneXbx4_Tk-Kw0TOJUdp2UtJGcsaY1YhANgGkoGXTNjOBDJ7qG5hHIRgPXjJu6yX1CCen6mmG2h47Wsqu5m6A34FLQo1oFO-lwr7y26u3E2Su19LdKSIzrlmeBg41A8DdzPkdNNhoYR52PnqOiDaeMCvoPuv_a68Xk-aMZUK0BJvgYAwwvEILVU2QqR6ZyZMoKlSPLBP4fwdikk_VPu9rxPdpfbjCgLQ |
CitedBy_id | crossref_primary_10_17235_reed_2023_9988_2023 crossref_primary_10_1093_jscr_rjae026 crossref_primary_10_1093_jscr_rjae612 crossref_primary_10_1186_s40792_023_01689_6 crossref_primary_10_1159_000539978 crossref_primary_10_1097_RCT_0000000000001541 crossref_primary_10_3389_fonc_2024_1335760 crossref_primary_10_1159_000538384 crossref_primary_10_22516_25007440_903 crossref_primary_10_3919_jjsa_85_927 crossref_primary_10_4251_wjgo_v16_i6_2295 crossref_primary_10_1177_20363613241242383 crossref_primary_10_1016_j_modpat_2024_100566 crossref_primary_10_1515_biol_2022_0774 crossref_primary_10_3390_cancers17071074 crossref_primary_10_4251_wjgo_v16_i12_4559 crossref_primary_10_1016_j_asjsur_2023_04_098 crossref_primary_10_12998_wjcc_v10_i27_9573 crossref_primary_10_7759_cureus_63141 |
Cites_doi | 10.1186/s13000-019-0815-3 10.1530/ERC-14-0410 10.1007/s00428-012-1212-4 10.1159/000501200 10.1186/s12957-021-02187-5 10.1186/s12935-019-1031-7 10.1097/MD.0000000000023271 10.1001/jamanetworkopen.2021.14180 10.1097/MD.0000000000002156 10.1038/modpathol.2016.220 10.1186/s12967-020-02293-0 10.1007/978-3-642-59655-1 10.1097/PAS.0b013e31826399d8 10.1158/2159-8290.CD-14-0617 10.1097/01.pas.0000157974.05397.4f 10.1177/106689690401200204 10.1245/s10434-014-3725-3 10.3390/medsci9030047 10.3390/jcm9010273 10.21037/jgo.2018.11.08 10.1530/ERC-17-0557 10.1007/s12328-019-01009-2 10.1002/dc.23107 10.1002/path.5556 10.14670/HH-18-045 10.17235/reed.2016.4315/2016 10.1136/jcp.46.2.183 10.1016/s0002-9440(10)64917-6 10.1038/modpathol.2016.150 10.1186/s40792-021-01152-4 10.3748/wjg.v21.i41.11740 10.1016/j.ejso.2019.08.002 10.1097/PAS.0000000000000169 10.1016/S0140-6736(15)00817-X 10.3389/fonc.2016.00148 10.32074/1591-951X-230 10.1097/MD.0000000000027348 10.1111/pin.12029 10.1093/ajcp/aqw028 10.18632/oncotarget.18678 10.1177/0003134820950000 10.1097/MPA.0b013e318264d073 10.1016/j.pan.2020.11.020 10.1056/NEJMoa1316158 10.1186/s40792-018-0454-z 10.3389/fonc.2021.709097 10.1016/j.pathol.2020.01.437 10.1016/j.dld.2011.07.010 10.1002/cncr.22179 10.1111/his.13975 10.1007/s00428-018-2366-5 10.1007/s00535-020-01756-x 10.1007/s00428-012-1348-2 10.1016/j.prp.2021.153593 10.1038/s41598-018-37707-z 10.1002/cam4.4031 10.3389/fsurg.2021.678853 10.1016/j.humpath.2020.12.008 10.3748/wjg.v27.i7.624 10.1056/NEJMoa1607427 10.14309/crj.2018.39 10.1007/s005950300048 10.1186/s12893-019-0546-0 10.1007/s12328-021-01420-8 10.3748/wjg.v25.i39.5991 10.2169/internalmedicine.4609-20 10.1159/000443612 10.1016/j.jcma.2015.04.002 10.1007/s12328-015-0623-6 10.1177/000313482008600224 10.1177/1066896917752443 10.1016/j.humpath.2017.08.036 10.1007/s12022-018-9522-y 10.1016/j.humpath.2017.12.009 10.1016/S1590-8658(16)30195-5 10.1002/1097-0142(19810801)48:3<833::aid-cncr2820480328>3.0.co;2-z 10.1080/0284186X.2021.1903077 10.14740/gr1323 10.1002/cncr.28721 10.1016/S1726-4901(09)70400-9 10.1111/1751-2980.12752 10.1186/s12957-017-1157-9 10.5230/jgc.2018.18.e16 10.1016/j.prp.2020.152869 10.3389/fonc.2020.01660 10.1007/s12022-020-09605-6 10.1016/j.ejso.2020.08.022 10.1111/his.14178 10.1007/s12022-016-9432-9 10.3390/cancers4010011 10.1016/s0242-6498(05)86164-4 10.1038/s41379-021-00978-5 10.1097/01.lab.0000079006.91414.be 10.1016/j.critrevonc.2019.02.012 10.1007/s00795-021-00294-6 10.1007/978-3-319-17235-4 10.2152/jmi.52.191 10.1200/PO.20.00487 10.3389/fmed.2015.00041 10.4274/balkanmedj.2017.1471 10.1016/j.ejso.2021.05.021 10.1007/s100249910040 10.1016/j.ejca.2014.08.004 10.1016/j.ando.2019.04.006 10.1136/bcr-2020-234855 10.1159/000369071 10.1159/000375449 10.1097/PAI.0000000000000969 |
ContentType | Journal Article |
Copyright | The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. 2022 |
Copyright_xml | – notice: The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. – notice: The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. 2022 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.3748/wjg.v28.i8.794 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Elpek GO. MiNENs of the gastrointestinal system |
EISSN | 2219-2840 |
EndPage | 810 |
ExternalDocumentID | PMC8900574 35317101 10_3748_wjg_v28_i8_794 |
Genre | Journal Article Review |
GroupedDBID | --- 123 29R 2WC 36B 53G 5VR 8WL AAKDD AAYXX ACGFO AENEX ALMA_UNASSIGNED_HOLDINGS CCEZO CHBEP CIEJG CITATION CS3 CW9 DIK DU5 E3Z EBS EJD F5P FA0 FRP GX1 HYE OK1 P2P RNS RPM TR2 XSB CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c390t-bb9926943367c8f86eec621fa53c84fb8b62367e96ae4a34c56c841211bd5303 |
ISSN | 1007-9327 2219-2840 |
IngestDate | Thu Aug 21 18:25:07 EDT 2025 Fri Jul 11 04:13:42 EDT 2025 Mon Jul 21 05:38:20 EDT 2025 Thu Apr 24 22:52:57 EDT 2025 Tue Jul 01 02:11:53 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 8 |
Keywords | Mixed adeno neuroendocrine carcinoma Gallbladder Mixed neuroendocrine–nonneuroendocrine neoplasms Pancreas Gastrointestinal system Liver |
Language | English |
License | The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c390t-bb9926943367c8f86eec621fa53c84fb8b62367e96ae4a34c56c841211bd5303 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Author contributions: Elpek GO performed the design of the article, obtained, analyzed and interpreted the data, and wrote the article. Corresponding author: Gulsum Ozlem Elpek, MD, Professor, Pathology , Akdeniz University Medical School, Dumlupınar bulvarı, Antalya 07070, Turkey. elpek@akdeniz.edu.tr |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8900574 |
PMID | 35317101 |
PQID | 2642328274 |
PQPubID | 23479 |
PageCount | 17 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8900574 proquest_miscellaneous_2642328274 pubmed_primary_35317101 crossref_primary_10_3748_wjg_v28_i8_794 crossref_citationtrail_10_3748_wjg_v28_i8_794 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-2-28 2022-Feb-28 20220228 |
PublicationDateYYYYMMDD | 2022-02-28 |
PublicationDate_xml | – month: 02 year: 2022 text: 2022-2-28 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | World journal of gastroenterology : WJG |
PublicationTitleAlternate | World J Gastroenterol |
PublicationYear | 2022 |
Publisher | Baishideng Publishing Group Inc |
Publisher_xml | – name: Baishideng Publishing Group Inc |
References | B20 B21 B22 B23 B24 B25 B26 B27 B28 B29 B30 B31 B32 B33 B34 B35 B36 B37 B38 B39 B1 B2 B3 B4 B5 B6 B7 B8 B9 B40 B41 B42 B43 B44 B45 B46 B47 B48 B49 B50 B51 B52 B53 B54 B55 B56 B57 B58 B59 B109 B107 B108 B105 B106 B103 B104 B101 B102 B100 B60 B61 B62 B63 B64 B65 B66 B67 B68 B69 B114 B115 B112 B113 B110 B111 B70 B71 B72 B73 B74 B75 B76 B77 B78 B79 B80 B81 B82 B83 B84 B85 B86 B87 B88 B89 B90 B91 B92 B93 B94 B95 B96 B97 B10 B98 B11 B99 B12 B13 B14 B15 B16 B17 B18 B19 |
References_xml | – ident: B36 doi: 10.1186/s13000-019-0815-3 – ident: B42 doi: 10.1530/ERC-14-0410 – ident: B110 doi: 10.1007/s00428-012-1212-4 – ident: B24 doi: 10.1159/000501200 – ident: B107 doi: 10.1186/s12957-021-02187-5 – ident: B30 doi: 10.1186/s12935-019-1031-7 – ident: B115 doi: 10.1097/MD.0000000000023271 – ident: B76 doi: 10.1001/jamanetworkopen.2021.14180 – ident: B100 doi: 10.1097/MD.0000000000002156 – ident: B33 doi: 10.1038/modpathol.2016.220 – ident: B5 doi: 10.1186/s12967-020-02293-0 – ident: B7 doi: 10.1007/978-3-642-59655-1 – ident: B80 doi: 10.1097/PAS.0b013e31826399d8 – ident: B104 doi: 10.1158/2159-8290.CD-14-0617 – ident: B78 doi: 10.1097/01.pas.0000157974.05397.4f – ident: B13 doi: 10.1177/106689690401200204 – ident: B85 doi: 10.1245/s10434-014-3725-3 – ident: B69 doi: 10.3390/medsci9030047 – ident: B15 doi: 10.3390/jcm9010273 – ident: B84 doi: 10.21037/jgo.2018.11.08 – ident: B67 doi: 10.1530/ERC-17-0557 – ident: B77 doi: 10.1007/s12328-019-01009-2 – ident: B81 doi: 10.1002/dc.23107 – ident: B39 doi: 10.1002/path.5556 – ident: B54 doi: 10.14670/HH-18-045 – ident: B53 doi: 10.17235/reed.2016.4315/2016 – ident: B86 doi: 10.1136/jcp.46.2.183 – ident: B103 doi: 10.1016/s0002-9440(10)64917-6 – ident: B38 doi: 10.1038/modpathol.2016.150 – ident: B9 – ident: B111 doi: 10.1186/s40792-021-01152-4 – ident: B22 doi: 10.3748/wjg.v21.i41.11740 – ident: B55 doi: 10.1016/j.ejso.2019.08.002 – ident: B98 doi: 10.1097/PAS.0000000000000169 – ident: B61 doi: 10.1016/S0140-6736(15)00817-X – ident: B56 doi: 10.3389/fonc.2016.00148 – ident: B12 doi: 10.32074/1591-951X-230 – ident: B43 doi: 10.1097/MD.0000000000027348 – ident: B113 doi: 10.1111/pin.12029 – ident: B18 – ident: B28 doi: 10.1093/ajcp/aqw028 – ident: B40 doi: 10.18632/oncotarget.18678 – ident: B74 doi: 10.1177/0003134820950000 – ident: B51 doi: 10.1097/MPA.0b013e318264d073 – ident: B26 – ident: B4 – ident: B101 doi: 10.1016/j.pan.2020.11.020 – ident: B59 doi: 10.1056/NEJMoa1316158 – ident: B63 doi: 10.1186/s40792-018-0454-z – ident: B73 doi: 10.3389/fonc.2021.709097 – ident: B105 doi: 10.1016/j.pathol.2020.01.437 – ident: B79 doi: 10.1016/j.dld.2011.07.010 – ident: B32 – ident: B23 doi: 10.1002/cncr.22179 – ident: B29 doi: 10.1111/his.13975 – ident: B46 doi: 10.1007/s00428-018-2366-5 – ident: B65 doi: 10.1007/s00535-020-01756-x – ident: B41 doi: 10.1007/s00428-012-1348-2 – ident: B102 doi: 10.1016/j.prp.2021.153593 – ident: B50 doi: 10.1038/s41598-018-37707-z – ident: B92 doi: 10.1002/cam4.4031 – ident: B106 doi: 10.3389/fsurg.2021.678853 – ident: B72 doi: 10.1016/j.humpath.2020.12.008 – ident: B75 doi: 10.3748/wjg.v27.i7.624 – ident: B45 – ident: B60 doi: 10.1056/NEJMoa1607427 – ident: B95 doi: 10.14309/crj.2018.39 – ident: B108 doi: 10.1007/s005950300048 – ident: B99 doi: 10.1186/s12893-019-0546-0 – ident: B91 doi: 10.1007/s12328-021-01420-8 – ident: B3 doi: 10.3748/wjg.v25.i39.5991 – ident: B89 doi: 10.2169/internalmedicine.4609-20 – ident: B58 doi: 10.1159/000443612 – ident: B47 doi: 10.1016/j.jcma.2015.04.002 – ident: B52 doi: 10.1007/s12328-015-0623-6 – ident: B64 doi: 10.1177/000313482008600224 – ident: B88 doi: 10.1177/1066896917752443 – ident: B35 doi: 10.1016/j.humpath.2017.08.036 – ident: B10 doi: 10.1007/s12022-018-9522-y – ident: B1 doi: 10.1016/j.humpath.2017.12.009 – ident: B70 doi: 10.1016/S1590-8658(16)30195-5 – ident: B87 doi: 10.1002/1097-0142(19810801)48:3<833::aid-cncr2820480328>3.0.co;2-z – ident: B66 doi: 10.1080/0284186X.2021.1903077 – ident: B112 doi: 10.14740/gr1323 – ident: B48 doi: 10.1002/cncr.28721 – ident: B109 doi: 10.1016/S1726-4901(09)70400-9 – ident: B49 doi: 10.1111/1751-2980.12752 – ident: B96 doi: 10.1186/s12957-017-1157-9 – ident: B34 doi: 10.5230/jgc.2018.18.e16 – ident: B93 doi: 10.1016/j.prp.2020.152869 – ident: B83 doi: 10.3389/fonc.2020.01660 – ident: B16 doi: 10.1007/s12022-020-09605-6 – ident: B21 doi: 10.1016/j.ejso.2020.08.022 – ident: B17 doi: 10.1111/his.14178 – ident: B2 doi: 10.1007/s12022-016-9432-9 – ident: B19 doi: 10.3390/cancers4010011 – ident: B20 doi: 10.1016/s0242-6498(05)86164-4 – ident: B31 doi: 10.1038/s41379-021-00978-5 – ident: B71 doi: 10.1097/01.lab.0000079006.91414.be – ident: B62 doi: 10.1016/j.critrevonc.2019.02.012 – ident: B8 – ident: B11 doi: 10.1007/s00795-021-00294-6 – ident: B27 doi: 10.1007/978-3-319-17235-4 – ident: B68 doi: 10.2152/jmi.52.191 – ident: B114 doi: 10.1200/PO.20.00487 – ident: B94 doi: 10.3389/fmed.2015.00041 – ident: B57 doi: 10.4274/balkanmedj.2017.1471 – ident: B82 doi: 10.1016/j.ejso.2021.05.021 – ident: B6 doi: 10.1007/s100249910040 – ident: B14 doi: 10.1016/j.ejca.2014.08.004 – ident: B25 doi: 10.1016/j.ando.2019.04.006 – ident: B97 doi: 10.1136/bcr-2020-234855 – ident: B37 doi: 10.1159/000369071 – ident: B44 doi: 10.1159/000375449 – ident: B90 doi: 10.1097/PAI.0000000000000969 |
SSID | ssj0023352 |
Score | 2.4579773 |
SecondaryResourceType | review_article |
Snippet | Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the digestive tract are a rare heterogeneous group of tumors that present many challenges in terms... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 794 |
SubjectTerms | Adenocarcinoma Aged Biopsy Gastrointestinal Tract - pathology Humans Male Minireviews Neuroendocrine Tumors - diagnosis |
Title | Mixed neuroendocrine–nonneuroendocrine neoplasms of the gastrointestinal system: An update |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35317101 https://www.proquest.com/docview/2642328274 https://pubmed.ncbi.nlm.nih.gov/PMC8900574 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKeOEFDfGvMJCRkHhAKcRxHJu3CQ2mocFLEXtAimzH2YpKWrUJoD3xHfiGfBLu4iRNuiENXqLKuXNS38W-O9_9TMjTUNhch3EWuCRLAu44Dwyeb8KyUKvYwapi0FE8fi8OP_Kjk_hkNHrXy1qqSjOx55fWlfyPVKEN5IpVsv8g2a5TaIDfIF-4goTheiUZH89-4O494mu4IltYrORrsxeiAlNY-neAcLEEY_nruk0MONXrcrVAxAj40NEs9bjOTbCwWmI0oG-9-sybHtiE7wBhPVceywlZPx1153UdzJeunm7fVnMYmOcfzudNqLgJNICPuinc9nMjRjXB3Ev6k-eGoGqTb_1MmPizi9tF1eeubs_XiH0Dg_z9y-nkG5OTmZx0bH1g7K0Fq0sjBAcGe0iBPwX-dCZT4L9GrjPwGVgbumm8bywuq7e-m3_hETyR_8Xw-UML5YLbsZ092zNHprvkZuNH0H2vFLfIyBW3yedaIehQ7L9__rqgCrRTBbrIKagC3VYF6lXhFd0vqFeEO2T65mD6-jBojs8IbKReloExSmGdchSJxMpcCuesYGGu48hKnhtpBML3OSW04zriNhbQjpB_JovBsrlLduD13H1C80QZLRTT1jGesVjnsC5YGNIsVgb83zEJ2hFLbQMtjyeczNPLJTQmzzr6pQdV-Svlk1YAKcx7uJmlYYSqdQqGPDgDkiVAc88LpOsrgoUFLOdwTJKBqDoCxFQf3ilmZzW2ulRYns0fXPkNH5Ibm49lj-yUq8o9Aju1NI9r_fsDxlecIQ |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mixed+neuroendocrine%E2%80%93nonneuroendocrine+neoplasms+of+the+gastrointestinal+system%3A+An+update&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Elpek%2C+Gulsum+Ozlem&rft.date=2022-02-28&rft.issn=1007-9327&rft.volume=28&rft.issue=8&rft.spage=794&rft.epage=810&rft_id=info:doi/10.3748%2Fwjg.v28.i8.794&rft.externalDBID=n%2Fa&rft.externalDocID=10_3748_wjg_v28_i8_794 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1007-9327&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1007-9327&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1007-9327&client=summon |